{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me look again.\n\nThe context has four entries. The first three are just the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\". The fourth entry has the same title but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's some formatting issues here. The user might have intended to provide a paper or article about lockdowns and their impact on infections.\n\nSo, the question is about defining a lockdown. The answer should be a general definition since the context doesn't provide specific details. The context mentions \"non-lockdown\" and \"implemented with lockdown\", which suggests that a lockdown is a public health measure to restrict movement to control disease spread. The date 24/3/2020 is likely when the lockdown was implemented, maybe in a specific country. But the user wants a definition, not the specific example.\n\nI need to make sure the answer is accurate. A lockdown typically involves strict restrictions on movement, closure of non-essential services, and stay-at-home orders. The context's focus on infections implies it's related to a pandemic, like COVID-19. The answer should explain that a lockdown is a measure to reduce the spread of infectious diseases by limiting social interactions. Since the context is about estimating infections, the lockdown's impact would be reducing transmission rates. The user might be looking for a concise definition based on the context provided, even if the context is a bit fragmented.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and social interactions in response to an infectious disease outbreak, such as the COVID-19 pandemic. It typically involves strict limitations on travel, closure of non-essential businesses, schools, and public spaces, and mandates for individuals to remain at home except for essential activities. The goal is to reduce the spread of the disease by minimizing contact between people, thereby lowering transmission rates and preventing healthcare systems from becoming overwhelmed. The context provided references lockdowns as part of efforts to estimate infections and assess their impact on public health.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, looking at the first passage, it lists several complications from most common to least. The main ones are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. That's a good list to start with.\n\nThen, in the third passage about the La Reunion Island outbreak, there's mention of neonates developing mengoencephalitis (probably a typo for meningoencephalitis). Also, six neonates had this, and there were fetal deaths. The fourth passage by Gerardin et al. talks about neonatal infections leading to encephalitis through vertical transmission. So encephalitis, especially in newborns, is another complication.\n\nI should also note that the elderly and those with underlying conditions are more severely affected. But the question is about complications, not risk factors. So focus on the specific medical issues listed. Let me compile all the complications mentioned:\n\n1. Respiratory failure\n2. Cardiovascular decompensation\n3. Meningoencephalitis\n4. Severe acute hepatitis\n5. Severe cutaneous effects\n6. Other central nervous system problems (like encephalitis)\n7. Kidney failure\n8. Neonatal encephalitis (from vertical transmission)\n9. Fetal deaths (though this is a complication for the fetus, not the mother)\n\nWait, the user might want all complications associated with CHIKV in general. So including both the general complications and those specific to neonates. Also, the answer should list them in order if possible. The first passage lists them from most common to least, so maybe present them in that order but also include the neonatal issues.\n\nMake sure to check for any other mentions. The third passage also mentions high morbidity in neonates. So the answer should include all these points. Let me structure the answer clearly, listing each complication and maybe noting specific cases like neonatal transmission leading to encephalitis.\n</think>\n\nThe complications associated with Chikungunya virus (CHIKV) include:  \n1. **Respiratory failure**  \n2. **Cardiovascular de",
      "retrieved_chunks": [
        "Title: Chikungunya: A Potentially Emerging Epidemic?\nPassage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: and complications.\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al. theorized that motherto-child transmission most likely happens transplacentally shortly before delivery .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: A similar study by Gerardin et al. reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.2777777777777778,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what Clade A contains based on the provided context. First, I need to look through the passages given.\n\nLooking at the first passage about the 1A swine lineage, it mentions that the 1A lineage has 1,889 viruses from 34 countries collected from 2010 to the present. They divided it into three second-order divisions. But the question is about Clade A, not 1A. Wait, the titles and passages mention 1A, 1C, and 1B lineages. The user is asking about Clade A, but the context doesn't mention a Clade A. The lineages are referred to as 1A, 1B, 1C, etc. Maybe there's a confusion between Clade A and lineage 1A? The user might have a typo or misunderstanding. \n\nLooking through all the passages again, none of them refer to a \"Clade A\" specifically. The first passage talks about the 1A lineage, which is split into three second-order divisions. The other passages discuss 1C and 1B lineages. Since there's no mention of Clade A in any of the provided texts, the answer would be that there's no information on Clade A here. The user might be mixing up the lineage designations. Alternatively, maybe they meant lineage 1A? If that's the case, then 1A contains 1,889 viruses from 34 countries. But since the question specifically says \"Clade A,\" and the context doesn't mention that, the answer should clarify that Clade A isn't discussed here.\n</think>\n\nThe provided context does not mention a \"Clade A.\" Instead, it discusses specific lineages such as **1A**, **1B**, and **1C** swine influenza A virus lineages. For example:  \n- The **1A lineage** contains 1,889 viruses from 34 countries (2010\u2013present).  \n- The **1C lineage** includes 315 viruses from 14 countries (China and South Korea).  \n- The **1B lineage** refers to human seasonal influenza viruses.  \n\nIf the question intended to ask about the **1A lineage**, it would contain 1,889 viruses from 34 countries, as",
      "retrieved_chunks": [
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents."
      ],
      "computed_relevance": 0.625,
      "computed_utilization": 0.625,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of the 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. I need to look through the provided passages to find relevant information.\n\nFirst, looking at the first passage: It mentions that the S2 subunit is highly conserved with 99% identity, but the S1 subunit is different. The second passage says the S1 subunit of 2019-nCoV shares around 70% identity with the bat SARS-like CoVs and human SARS-CoV. Also, the core domain of the RBD (receptor-binding domain) is highly conserved, but most amino acid differences are in the external subdomain, which interacts with the host receptor. \n\nAnother part in the third passage states that the external subdomain of the Spike's RBD in 2019-nCoV has only 40% identity with other SARS-related coronaviruses. Wait, that seems conflicting. Wait, the second passage says 70% identity for the S1 subunit overall, but the core RBD is conserved, while the external part has differences. The third passage mentions 40% for the external subdomain. So maybe the S1 subunit as a whole has 70% identity, but specific regions like the external subdomain have lower identity. \n\nSo putting it together: The S1 subunit of 2019-nCoV has about 70% identity with SARS-like CoVs and human SARS-CoV. The core RBD is conserved, but the external part, which is involved in receptor interaction, has more differences. Also, some bat SARS-related CoVs have deletions in the RBD. Therefore, the S1 subunit is less conserved compared to S2, with significant differences in the receptor-binding region that might affect host interaction.\n</think>\n\nThe S1 subunit of the 2019-nCoV (SARS-CoV-2) shares **approximately 70% amino acid identity** with the S1 subunits of bat SARS-like coronaviruses (SARSr-CoVs) and human SARS-CoV. While the **core domain of the receptor-binding domain (RBD)** within the S1 subunit is",
      "retrieved_chunks": [
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV. But some\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: bat, civet and human SARS coronaviruses. However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b. The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.15789473684210525,
      "computed_utilization": 0.15789473684210525,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" I need to answer based on the provided context.\n\nFirst, I'll go through each of the passages to gather relevant information. \n\nIn the first passage, it mentions that B. subtilis is a probiotic used to treat intestinal diseases like colitis. It helps restore gut microflora by increasing beneficial bacteria and decreasing harmful ones. Also, it maintains gut barrier integrity and reduces inflammation. The study by Bene et al., 2017 is cited here.\n\nThe second passage talks about Bacillus and Lactobacillus species in fermented foods and probiotics. Specific products like Enterogermina and Biosubtyl are listed as containing these bacteria. However, this passage is more about their use in food and commercial products, but it doesn't directly mention B. subtilis's role beyond being a probiotic component.\n\nThe third passage discusses Bacillus species in the gut. It states that Bacillus was not traditionally considered part of the normal microbiome but recent studies show they are present in significant amounts in the gut, especially in healthy individuals. This might relate to B. subtilis's presence in the GIT (gastrointestinal tract).\n\nThe fourth passage focuses on the substances produced by B. subtilis: surfactins, fengycins, and iturins. It notes their antimicrobial and antiviral properties, as well as their role in modulating inflammation by affecting cytokines.\n\nPutting this together, Bacillus subtilis is a probiotic bacterium that's part of the Bacillus genus. It's used in treating intestinal issues, helps balance gut flora, produces beneficial compounds, and has anti-inflammatory effects. It's found in probiotic products and fermented foods. Also, despite being a soil organism, it's now recognized as a resident of the human gut microbiome.\n\nI need to make sure the answer includes its role as a probiotic, specific health benefits (like treating colitis, restoring gut flora), the substances it produces (surfactins, etc.), and its presence in the gut. Also mention that it's used in commercial probiotics and fermented foods. Avoid any information not in the context, like unrelated uses or other species unless necessary.\n</think>\n\nBacillus subtilis is a probiotic bacterium belonging to the Bacillus genus, recognized for its beneficial roles in maintaining intestinal health.",
      "retrieved_chunks": [
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased . B. subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B. subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp. as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines ."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided contexts to find any mentions of research related to such pandemics.\n\nLooking at the first context, it discusses the 1889 pandemic which had three major waves, with the 1892 wave being the most intense. It also mentions the 1918 pandemic's herald waves possibly stretching back to 1915. However, the question is about single-wave pandemics, so this might not be directly relevant unless there's a mention of single-wave cases here. The passage doesn't explicitly talk about single-wave pandemics, so maybe this isn't the right context.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It mentions research on convalescent plasma treatment and studies on the origins and pathogenesis of the virus. The 2009 pandemic is noted, but again, the passage doesn't specify if it was a single wave. However, the focus here is on research done during that pandemic, not necessarily about single-wave pandemics.\n\nThe third context is an economic analysis of mitigation strategies for five pandemic severity categories. It references studies using simulation models and considers varying intervention durations. The 2009 pandemic data is used for health outcome probabilities. This seems more about modeling and economic impact rather than the structure of the pandemic waves.\n\nThe fourth context discusses the temporal patterns of influenza in Taiwan, specifically the 2009 pH1N1 pandemic. It mentions a multi-wave epidemic and the use of a Richards model variation to analyze turning points between waves. This is about multi-wave, not single-wave, so again, not directly relevant.\n\nPutting this together, none of the contexts explicitly mention research on severe, single-wave pandemics. The 1889 pandemic had multiple waves, the 2009 pandemic is discussed but not in terms of wave count, and the economic analysis uses the 2009 data but again doesn't specify wave structure. The user's question might not be directly addressed by the provided contexts. However, maybe the first context's mention of the 1889 pandemic having three waves and the 1892 wave being the most intense could imply that some research has looked into the intensity of specific waves, but not necessarily single-wave events. Since",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking \"How many reported viral pneumonia?\" based on the provided context. I need to look through the given passages to find any numbers related to viral pneumonia cases.\n\nFirst, looking at the first context about the 2019-nCoV. It mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection as of January 26, 2020. That's a specific number related to viral pneumonia caused by the novel coronavirus. The other contexts are about influenza. The second and third passages discuss bacterial co-infections in H1N1 cases and attack rates during pandemics, but they don't give a specific number of reported viral pneumonia cases. The fourth passage talks about pneumonia in adults with seasonal influenza but again doesn't provide a total number of cases.\n\nThe question is asking for the number of reported viral pneumonia cases. The only passage that provides a specific number is the first one regarding 2019-nCoV. The other contexts don't mention a total number of viral pneumonia cases, just statistics about influenza in general. So the answer should be the 2744 confirmed cases from the first context. I need to make sure there's no other number I missed. Let me check again. The first passage says 2744 confirmed cases. The rest don't have a specific number. So the answer is 2744.\n</think>\n\nThe context provided about the 2019 novel coronavirus (2019-nCoV) states that as of 26 January 2020, there were **2,744 confirmed cases of pneumonia** caused by 2019-nCoV infection. The other contexts discuss influenza-related pneumonia but do not provide specific numerical data on reported viral pneumonia cases. \n\n**Answer:** 2,744 reported cases of viral pneumonia (2019-nCoV).",
      "retrieved_chunks": [
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days .\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density.\n\nTitle: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01]."
      ],
      "computed_relevance": 0.09090909090909091,
      "computed_utilization": 0.09090909090909091,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the title mentions \"MERS coronavirus: diagnostics, epidemiology and transmission.\" The passage starts by saying, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. It also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. \n\nI should check the other passages to see if there's any conflicting information. The second passage talks about genome analyses showing single nucleotide differences and specific regions of the genome. The third passage discusses vigilance and whole genome sequencing but doesn't contradict the first answer. The fourth passage mentions genetic recombination studies but again doesn't conflict with the initial method mentioned.\n\nSo the key point here is the use of high throughput or deep sequencing methods. The first passage clearly states this as the primary method. The answer should reflect that most analysis has been done using these methods for complete genome deduction. I need to make sure to paraphrase the original sentence but keep the essential information. Also, note that subgenomic sequencing was less frequently used during MERS-CoV studies, as mentioned in the first passage. But the main answer is about the primary method, which is deep sequencing.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach enabled comprehensive genomic analysis in a single experiment with repeated measurements of nucleotide positions, marking MERS-CoV as the first virus to be widely studied using such techniques for an emerging global outbreak. Subgenomic sequencing, previously common in viral studies, was less frequently utilized during MERS-CoV research.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC"
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant information.\n\nFirst, looking at the first context: They mention using split-GFP-tagged viral proteins and monitoring GFP expression during passaging with immunofluorescence microscopy. But the question is about tracking the spread, so maybe this isn't the main one.\n\nSecond context: They used an inverted fluorescence microscope to monitor plates after applying an overlay. They imaged a square subset of each well using a CellInsight CX5 platform with a 4X objective. The settings were standardized, and images showed GFP cells in white. This seems like in vitro tracking over time.\n\nThird context: Talks about in vivo imaging using multi-photon intravital microscopy. They mention mouse lines with reporter genes like EGFP and mCherry. The strong expression allows long-term tracking without bleaching, and they can visualize small structures. This is about in vivo tracking.\n\nFourth context: They used IVIS for whole-organ imaging of lungs ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. They observed infection starting in the respiratory tract and spreading deeper. This is about in vivo spread in mice.\n\nSo the answer should combine methods from different contexts. The spread was tracked using fluorescence microscopy (inverted microscope, CellInsight platform) in cell cultures, and in vivo using multi-photon intravital microscopy and IVIS for whole-organ imaging. Also, flow cytometry was used to analyze specific cell types. The key is to mention both in vitro and in vivo methods, the specific imaging techniques, and maybe the tools like IVIS and CellInsight.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using a combination of **in vitro** and **in vivo** imaging techniques.  \n\n1. **In vitro**:  \n   - **Fluorescence microscopy**: Plates were monitored with an inverted fluorescence microscope to detect GFP expression. A high-content screening platform (CellInsight CX5) captured periodic images of GFP-expressing cells in culture wells, using standardized settings (e.g., fixed exposure time).  \n   - **Immunofluorescence microscopy**: GFP expression was monitored during cell passaging to track stable expression in transduced cell lines.  \n\n2. **In vivo**:  \n   - **Multi-photon",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .\n\nTitle: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 0.4666666666666667,
      "computed_utilization": 0.5333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages related to CT disinfection procedures. \n\nFirst, I need to look through each of the provided passages. The first one mentions \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination.\" The second and third titles are similar but mention \"Fever-CT disinfection\" and \"fever-CTs after sterilization.\" The fourth passage says the equipment is prepared to disinfect the imaging equipment immediately after the examination.\n\nPutting this together, the key points seem to be that after examining a suspected COVID-19 case, the CT scanner needs to be disinfected. The term \"immediately after the examination\" is mentioned, which suggests that the procedure should be done right after the exam. Also, the use of sterilization procedures is implied. \n\nThe answer should probably mention that the CT scanner should be disinfected immediately after the examination using appropriate sterilization methods. The context doesn't specify the exact disinfectants or steps, but the main idea is the timing and the fact that it's done after each suspected case. I need to make sure the answer reflects the information given without adding external knowledge. Since all the passages emphasize immediate disinfection post-examination, that's the core of the answer.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** of a suspected or confirmed COVID-19 case. The context emphasizes that sterilization/ disinfection should occur promptly after the procedure to prevent contamination, ensuring the equipment is prepared for subsequent use. Specific protocols likely include using appropriate disinfectants and following established sterilization guidelines for medical imaging equipment.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures.\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}